Area of research
Genetics · Epidemiology
Research interest
Research interests include Glioma Diagnosis and Treatment, Meningioma and schwannoma management, Single-cell and spatial transcriptomics, and Monoclonal and Polyclonal Antibodies Research.
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma
Imlunestrant a next-generation oral SERD overcomes ESR1 mutant resistance in estrogen receptor–positive breast cancer
The effect of TERT promoter mutation on predicting meningioma outcomes: a multi-institutional cohort analysis
Phase I Study of Adavosertib with Radiotherapy and Temozolomide in Newly Diagnosed Glioblastoma and Intratumoral Drug Levels in Recurrent Glioblastoma
Abstract 7152: High-dimensional, single-cell analysis and transcriptional profiling reveal novel correlatives of response to PARP inhibition plus PD-1 blockade in triple-negative breast cancer
cIMPACT-NOW update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas
Skin immune-mesenchymal interplay within tertiary lymphoid structures promotes autoimmune pathogenesis in hidradenitis suppurativa
Contemporary prognostic signatures and refined risk stratification of gliomas: An analysis of 4400 tumors
Cell state dependent effects of Bmal1 on melanoma immunity and tumorigenicity
92 High-dimensional, single-cell analysis and transcriptional profiling reveal novel correlatives of response to PARP inhibition plus PD-1 blockade in triple-negative breast cancer
Multiplexed 3D atlas of state transitions and immune interaction in colorectal cancer
BRAF–MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses
Lymphocyte networks are dynamic cellular communities in the immunoregulatory landscape of lung adenocarcinoma
A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4
Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization
Comprehensive analysis reveals potential therapeutic targets and an integrated risk stratification model for solitary fibrous tumors
Molecular Landscape and Contemporary Prognostic Signatures of Gliomas
Copper induces cell death by targeting lipoylated TCA cycle proteins
Oncometabolite <scp>d</scp> -2HG alters T cell metabolism to impair CD8 <sup>+</sup> T cell function
Spatial genomics maps the structure, nature and evolution of cancer clones
A human breast atlas integrating single-cell proteomics and transcriptomics
Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic <i>NF2</i> Mutations
Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features
HSF2 cooperates with HSF1 to drive a transcriptional program critical for the malignant state
Abstract P2-07-13: High-dimensional, single-cell analysis and transcriptional profiling reveal novel correlatives of response to PARP inhibition plus PD-1 blockade in triple-negative breast cancer
MCMICRO: a scalable, modular image-processing pipeline for multiplexed tissue imaging
Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy
A molecularly integrated grade for meningioma
Antigen dominance hierarchies shape TCF1+ progenitor CD8 T cell phenotypes in tumors